Professor Clarke is the Director of The European Cancer Stem Cell Research Institute. He is based at the School of Biosciences, where he is also leader of the School's Pathophysiology and Repair Research Division.
Doctor Matt Smalley is our first Senior Lecturer here at the European Cancer Stem Cell Research Institute at Cardiff University and he is a leader in breast cancer research.
Professor Peter Barrett-Lee is a full time Consultant Clinical Oncologist, Professor of Oncology in the School of Medicine at Cardiff University and lead specialist in breast cancer at Velindre NHS Trust.
Professor Alan Burnett is Head of Haematology in the Cardiff Department of Medical Genetics, Haematology and Pathology.
Professor Burnett has been key to Cardiff’s recognition for its world-class research into the adult leukaemia.
Professor Malcolm Mason is head of the Oncology and Palliative Medicine Section at the School of Medicine. Based at Velindre Hospital, he is also Director of the Wales Cancer Bank.
Professor Chris McGuigan is Professor of Medicinal Chemistry in the Welsh School of Pharmacy. His laboratory is extremely active in the discovery and development of drugs for a number of diseases.
Dr Simon Reed is a reader in Cancer Studies at the School of Medicine and a member of the Cancer Interdisciplinary Research Group. His research looks at how the body repairs its DNA at the molecular level.
Professor Julian Sampson is Head of the Institute of Medical Genetics at Cardiff University and also Head of the School of Medicine’s Department of Genetics, Haematology and Pathology.
Bringing together a range of scientific fields for the first time, The European Cancer Stem Cell Research Institute draws on the expertise of the Schools of Biosciences, Medicine and Pharmacy, as well as experts from a number of research centres across the University.
Led by the Institute Director, Professor Alan Clarke, the Institute will create new opportunities for a Professor, Senior Lecturers/Lecturers, Research Fellows and post-graduate students, all of the highest calibre. They will work with existing world-leading teams in basic biomedical science, genetic, drug development and clinical trials, creating a UK-based hub which will be the European centre for cancer stem cell research.